Wang S, Ding YB, Chen GY, Xia JG, Wu ZY Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric World J Gastroenterol, 2004, 10(12), 1815- Ling LJ, Wang S*, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F A novel mouse model of human breast cancer stem-like cells with high CD44+CD24- /lower phenotype metastasis to human Chin Med J (Engl), 2008, 121(20), 1980- Ding Q, Yang LX, Yang HW, Jiang C, Wang YF, Wang S* Cytotoxic and antibacterial triterpenoids derivatives from Clematis J Ethnopharmacol, 2009, 126(3), 382- Wang J, Xia TS, Liu XA, Ding Q, Du Q, Yin H, Wang S* A novel orthotopic and metastatic mouse model of breast cancer in human mammary Breast Cancer Res Treat, 2010, 120(2), 337- Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW, Liu XA, Dong M, Du Q, Ling LJ, Zha XM, Fu W, Wang S*Human tissue-specific microenvironment: an essential requirement for mouse models of breast Oncol Rep, 2010, 24(1), 203- Liu X, Wang Z, Yu J, Lei G, Wang S* Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis Breast Cancer Res Treat, 2010, 124(3), 821- Zhu J, Meng X, Yan F, Qin C, Wang M, Ding Q, Li P, Yang J, Ju X, Zhang Z, Wang S*, Yin C A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese J Hum Genet, 2010, 55(4), 236- Ling LJ, Lu C, Zhou GP, Wang S* Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer Cancer Biol Ther, 2010, 10(11), 1115- Zhou WB, Yin H, Liu XA, Zha XM, Chen L, Dai JC, Tao AD, Chen L, Ma JJ, Ling LJ, Wang S* Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer BMC Cancer, 2010, 10, Zou J, Zhang X, Yang H, Zhu Y, Ma H, Wang S* Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein Ann Vasc Surg, 2011, 25(4), 538- Zhou WB, Ding Q, Chen L, Liu XA, Wang S* Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized Breast Cancer Res Treat, 2011, 128(3), 625- Zhou WB, Liu XA, Dai JC, Wang S* Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the Can J Surg, 2011, 54(5), 300- Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S* The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysisJ Cancer Res Clin Oncol, 2011, 137(7), 1053- Ni XJ, Xia TS, Zhao YC, Ma JJ, Zhao J, Liu XA, Ding Q, Zha XM, Wang S* Postmenopausal hormone therapy is associated with in situ breast cancer risk Asian Pac J Cancer Prev, 2012, 13(8), 3917- Wang M, Zhou W, Zhao Y, Xia T, Zha X, Ding Q, Liu X, Zhao Y, Ling L, Chen L, Wang S*A novel finding of sentinel lymphatic channels in early stage breast cancer patients: which may influence detection rate and false-negative rate of sentinel lymph node PLoS One, 2012, 7(12), Chen L, Zhou WB, Zhao Y, Liu XA, Ding Q, Zha XM, Wang S* Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERalpha signaling Int J Oncol, 2012, 40(6), 1986- Zhou W, Zha X, Liu X, Ding Q, Chen L, Ni Y, Zhang Y, Xu Y, Chen L, Zhao Y, Wang S* US-guided percutaneous microwave coagulation of small breast cancers: a clinical Radiology, 2012, 263(2), 364- Wang X, Wang G, Zhao Y, Liu X, Ding Q, Shi J, Ding Y, Wang S* STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in Biomed Res, 2012, 26(5), 325- Xu L, Ju XB, Li P, Wang J, Shi ZM, Zheng MJ, Xue DD, Xu YJ, Yin YM, Wang S*, You YP Association between the Ku70-1310C/G promoter polymorphism and cancer risk:a meta- Asian Pac J Cancer Prev, 2012, 13(2), 683- Zhao YC, Ni XJ, Wang MH, Zha XM, Zhao Y, Wang S* Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer Med Oncol, 2012, 29(4), 2594- Zhou W, He Z, Xue J, Wang M, Zha X, Ling L, Chen L, Wang S*, Liu X Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph PLoS One, 2012, 7(4), Zhou W, Ding Q, Liang X, He Z, Zha X, Liu X, Wang S* The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based PLoS One, 2012, 7(5), Zhou W, Ding Q, Liu X, Jiang Y, Chen L, Zhang Y, Xia T, Wang S* Percutaneous microwave coagulation for eradication of VX2 tumors subcutaneously in World J Surg Oncol, 2012, 10, Zheng MJ, Wang J, Chen YW, Xu L, Xue DD, Fu W, Zhang YF, Du Q, Zhao Y, Ling LJ, Ding Q, Liu XA, Zha XM, Zheng W, Xia TS, Wang S*A novel mouse model of gastric cancer with human gastric microenvironment Cancer Lett, 2012, 325(1), 108- Liu X, Qin Z, Shen H, Xue J, Jiang Y, Hu Z, Shen H, Wang S* Genetic variants at 5p12 and risk of breast cancer in Han C J Hum Genet, 2012, 57(10), 638- Xia TS, Shi JP, Ding Q, Liu XA, Zhao Y, Liu YX, Xia JG, Wang S*, Ding YB Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer Med Oncol, 2012, 29(2), 448- Chen L, Zhou WB, Zhao Y, Liu XA, Ding Q, Zha XM, Wang S* Bloody nipple discharge is a predictor of breast cancer risk: a meta- Breast Cancer Res Treat, 2012, 132(1), 9- Cui YY, Qian JM, Yao AH, Ma ZY, Qian XF, Zha XM, Zhao Y, Ding Q, Zhao J, Wang S*, Wu J SOD mimetic improves the function, growth, and survival of small-size liver grafts after transplantation in Transplantation, 2012, 94(7), 687- Xia TS, Wang GZ, Ding Q, Liu XA, Zhou WB, Zhang YF, Zha XM, Du Q, Ni XJ, Wang J, Miao SY, Wang S* Bone metastasis in a novel breast cancer mouse model containing human breast and human Breast Cancer Res Treat, 2012, 132(2), 471- Ni X, Ma J, Zhao Y, Wang Y, Wang S* Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian Br J Clin Pharmacol, 2013, 75(1), 26- Pan H, Xia K, Zhou W, Xue J, Liang X, Cheng L, Wu N, Liang M, Wu D, Ling L, Ding Q, Chen L, Zha X, Liu X, Wang S* Low serum creatine kinase levels in breast cancer patients: a case-control PLoS One, 2013, 8(4), Zhou W, Pan H, Liang M, Xia K, Liang X, Xue J, Cheng L, Xue J, Chen S, Liu X, Ding Q, Ling L, Wang S* Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control World J Surg Oncol, 2013, 11, Ni X, Zhao Y, Ma J, Xia T, Liu X, Ding Q, Zha X, Wang S* Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer J Biomed Res, 2013, 27(6), 478- Zhou W, Liang M, Pan H, Liu X, Jiang Y, Wang Y, Ling L, Ding Q, Wang S* Comparison of ablation zones among different tissues using 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine PLoS One, 2013, 8(8), Zhou W, Liu X, Ding Q, Zha X, Wang S* Long-term outcomes of breast cancer ablationRadiology, 2013, 269(1), 309- Zhou W, Ding Q, Pan H, Wu N, Liang M, Huang Y, Chen L, Zha X, Liu X, Wang S* Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control BMC Cancer, 2014, 14, Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X, Ding Q, Zha X, Sha J, Wang S* Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase Cancer Sci, 2014, 105(1), 18- Miao SY, Zhou W, Chen L, Wang S*, Liu XA Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244,768 Asia Pac J Clin Oncol, 2014, 10(2), 101- Yang T, Xu F, Zhao Y, Wang S*, Yang M, Chen Y A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast Proteomics Clin Appl, 2014, 8(9-10), 773- Ren Y, Han X, Yu K, Sun S, Zhen L, Li Z, Wang S* microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer Mol Med Rep, 2014, 10(1), 315- Chen J, Jiang P, Wang HJ, Zhang JY, Xu Y, Guo MH, Zhang B, Tang CY, Cao HY, Wang S* The efficacy of molecular subtyping in predicting postoperative recurrence in breast-conserving therapy: a 15-study meta- World J Surg Oncol, 2014, 12, Zhou W, Jiang Y, Chen L, Ling L, Liang M, Pan H, Wang S, Ding Q, Liu X, Wang S* Image and pathological changes after microwave ablation of breast cancer: a pilot Eur J Radiol, 2014, 83(10), 1771- 王水，張?？?，趙同生, Hassab 手術(shù)后肝硬變大鼠動(dòng)脈血酮體比改變的意義, 南京醫(yī)學(xué)院學(xué)報(bào), 1991, (04), 302- 王水，劉訓(xùn)良，陸輝，孔連寶, B 型 Niemann-Pick 病脾臟切除一例, 南京醫(yī)學(xué)院學(xué)報(bào), 1993, (02), 王水，沈亞勛, 老年原發(fā)性膽囊癌誤診 27 例分析, 南京醫(yī)科大學(xué)學(xué)報(bào), 1997, (02), 王水，查小明，武正炎, 原發(fā)性甲狀旁腺機(jī)能亢進(jìn)癥術(shù)后低鈣血癥及其處理, 江蘇醫(yī)藥, 2001, (03), 王水，查小明, 三苯氧胺對(duì)絕經(jīng)后乳腺癌患者子宮和卵巢的影響, 南京醫(yī)科大學(xué)學(xué)報(bào), 2001, (04), 320- 王水，林紅軍，查小明, 三苯氧胺對(duì)乳腺癌患者子宮卵巢的影響, 中國(guó)腫瘤臨床, 2001, (05), 389- 王水，武正炎，范萍，查小明, 血管內(nèi)皮細(xì)胞生長(zhǎng)因子在乳腺癌組織中的表達(dá)及其生物學(xué)意義, 南京醫(yī)科大學(xué)學(xué)報(bào), 2001, (06), 503- 王水，查小明，范萍，武正炎, 乳腺癌染料法前哨淋巴結(jié)活檢的臨床意義, 中華腫瘤雜志, 2002, (02), 王水，劉曉，劉曉安，查小明，符德元，甄林林，范萍，武正炎，乳腺癌前哨淋巴結(jié)活檢染料和手術(shù)時(shí)機(jī)選擇，腫瘤學(xué)雜志, 2002, (06), 332- 王水，劉曉安，武正炎，影響染料法乳腺癌前哨淋巴結(jié)活檢成功率的一些因素外科理論與實(shí)踐, 2004, (02), 107- 王水，范萍，武正炎，乳腺癌前哨淋巴結(jié)淋巴細(xì)胞亞群的初步研究，中華腫瘤雜志, 2004, (04), 31- 王水，劉曉安，趙燕超，武正炎，采用異硫藍(lán)和美藍(lán)行乳腺癌前哨淋巴結(jié)活檢的臨床價(jià)值，江蘇醫(yī)藥, 2004, (07), 506- 王水，范萍，劉曉安，武正炎，乳腺癌骨髓和前哨淋巴結(jié)微小轉(zhuǎn)移檢測(cè)的臨床研究，中華普通外科雜志, 2004, (09), 54- 耿強(qiáng)，王水，范萍，劉曉安，鄭偉，乳腺癌前哨淋巴結(jié)和骨髓和外周血微小轉(zhuǎn)移的聯(lián)合檢測(cè)，腫瘤防治雜志, 2005, (02), 85- 徐鯤，劉曉安，王水，張小林，陸輝，乳腺癌前哨淋巴結(jié)活檢染料選擇的實(shí)驗(yàn)研究，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2005, (03), 201- 徐鯤，劉曉安，王水，王振中，乳腺癌前哨淋巴結(jié)活檢常用染料效果實(shí)驗(yàn)研究，現(xiàn)代腫瘤醫(yī)學(xué), 2005, (04), 433- 徐鯤，劉曉安，王水，周青，耿強(qiáng)，中華墨汁作為乳腺癌前哨淋巴結(jié)活檢示蹤劑的實(shí)驗(yàn)研究，腫瘤防治雜志, 2005, (05), 321-王水，劉曉安，早期乳腺癌治療中前哨淋巴結(jié)活檢應(yīng)用價(jià)值探討，中國(guó)實(shí)用外科雜志, 2006, (04), 312- 王水，趙佳，劉曉，甲狀腺炎合并甲狀腺功能亢進(jìn)的手術(shù)治療，中國(guó)實(shí)用外科雜志, 2006, (07), 503- 王水，劉曉安，趙佳，耿強(qiáng)，劉力嘉，染料法乳腺癌前哨淋巴通道的研究，中華外科雜志, 2006, (11), 748- 曹勤洪，王水，徐鯤 ，劉曉安，劉力嘉，中華墨汁作為前哨淋巴結(jié)活檢新型示蹤劑的實(shí)驗(yàn)研究，The Chinese-German Journal of Clinical Oncology, 2006, (01), 36- 郝漢霞，王水，劉力嘉，范萍，杜青，張偉民，王聰， 乳腺癌腫瘤相關(guān)巨噬細(xì)胞中 HIF-2α/EPAS1 表達(dá)與血管生成的關(guān)系，中華腫瘤防治雜志, 2006, (03), 169- 王鋒，王水，陸輝，鄭偉，孫琳， 乳腺癌組織中 p21~(WAF1)、CDK4 的表達(dá)及臨床意義，江蘇醫(yī)藥, 2006, (06), 520- 趙佳，劉曉安，王水，劉力嘉 免疫組織化學(xué)和RT-PCR法檢測(cè)乳腺癌骨髓和前哨淋巴結(jié)微小轉(zhuǎn)移的臨床研究現(xiàn)代腫瘤醫(yī)學(xué), 2006, (07), 813- 鄒漢青，王水，林紅軍，張智弘，劉曉安，彭曉靜， 活體兔肌肉組織微波固化后病理學(xué)變化的實(shí)驗(yàn)研究 中華腫瘤防治雜志, 2006, (07), 489- 凌立君，魏惠華，曾莉，劉曉安，王鳳良，趙佳，賈曉斌，王水，鹽酸川芎嗪微囊的制備及質(zhì)量控制，中成藥, 2006, (11), 1692- 趙佳，王水，劉曉安，劉力嘉，IHC 和 PCR 法聯(lián)合檢測(cè)乳腺癌前哨淋巴結(jié)的微轉(zhuǎn)移，中華腫瘤防治雜志, 2006, (16), 1229- 王水，劉曉安，趙佳，耿強(qiáng)，劉力嘉，聯(lián)合法觀察前哨淋巴通道的臨床研究，中華乳腺病雜志(電子版), 2007, (01), 35- 王鋒，王水，宣卓琦，孫琳，陸輝，乳腺癌細(xì)胞中 p53、C-erbB-2、p21~(WAF1)和 CDK4 的表達(dá)及臨床意義， 南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2007, (01), 70- 凌立君，趙佳，王水，劉曉安，核素法前哨淋巴通道的研究，中華乳腺病雜志(電子版), 2007, (02), 16- 王鋒，夏添松，夏建國(guó)，陳國(guó)玉，王水胃腸道間質(zhì)腫瘤伴肝轉(zhuǎn)移 18 例臨床分析，臨床腫瘤學(xué)雜志, 2007, (03), 191- 許健，王水，許立生，杜青，劉曉安，乳腺癌細(xì)胞系中腫瘤干細(xì)胞相關(guān)亞群初步研究，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2007, (04), 350- 謝錫駒，王水，鄭偉，查小明，乳腺癌患者血清 IGF-Ⅱ水平及其在腫瘤組織中的表達(dá)，江蘇醫(yī)藥, 2007, (07), 672- 王鳳良，凌立君，沈恩超，劉曉安，王水，血清 Tracp5b 診斷乳腺癌骨轉(zhuǎn)移的臨床價(jià)值，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2007, (07), 702- 許健; 王水;許立生，杜青，劉曉安，趙佳，雌激素對(duì) MCF-7 中腫瘤干細(xì)胞相關(guān)亞群影響的實(shí)驗(yàn)研究，中華腫瘤防治雜志, 2007, (09), 650- 陳龍舟，趙佳，王鳳良，凌立君，劉曉安，王水 淋巴結(jié)陰性乳腺癌骨髓微小轉(zhuǎn)移聯(lián)合檢測(cè)的臨床研究，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2007, (09), 939- 許立生，王水，許健，杜青，無(wú)血清懸浮法培養(yǎng)MCF-7細(xì)胞系并篩選該細(xì)胞系中腫瘤干細(xì)胞相關(guān)亞群的初步研究，中華腫瘤防治雜志, 2007, (10), 736- 謝暉，曹勤洪，夏鍇，劉曉安，王水乳腺癌組織 APRG1 基因表達(dá)的初步研究，江蘇醫(yī)藥, 2007, (10), 1006- 劉月仙，夏添松，李俊芳，王水，共刺激分子 B7-2 基因轉(zhuǎn)染抑制乳腺癌生長(zhǎng)和轉(zhuǎn)移的實(shí)驗(yàn)研究，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2007, (11), 1228- 孫蓉，凌立君，劉曉安，趙佳，耿強(qiáng)，王水，聯(lián)合法前哨淋巴通道的臨床研究，中華腫瘤防治雜志, 2007, (17), 1328- 王鳳良，王水，凌立君，沈恩超，劉曉安，血清 Tracp5b 診斷乳腺癌骨轉(zhuǎn)移及評(píng)價(jià)雙膦酸鹽治療療效的臨床意義，中華腫瘤防治雜志, 2007, (21), 1628- 王水，趙佳，乳腺癌前哨淋巴結(jié)活檢的研究進(jìn)展，中華普外科手術(shù)學(xué)雜志(電子版), 2008, (02), 147- 王水，趙佳，早期乳腺癌前哨淋巴結(jié)活檢術(shù)的進(jìn)展，中華乳腺病雜志(電子版), 2008, (03), 255- 王水，重視老年甲狀腺疾病診斷與治療，實(shí)用老年醫(yī)學(xué), 2008, (04), 243- 李昌文，劉曉安，林紅軍，章宜芬，王水冷循環(huán)微波固化家豬乳腺實(shí)驗(yàn)研，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2008, (01), 16- 沈恩超，凌立君，王水，劉曉安，朱海清，李鳳山，SDF-1、CXCR4 在乳腺癌組織及轉(zhuǎn)移淋巴結(jié)中的表達(dá)及其意義，江蘇醫(yī)藥, 2008, (04), 367- 錢(qián)超，夏鍇，張靜靜，杜青，劉曉安，王水缺氧條件下雷帕霉素抗人乳腺癌 MCF-7 細(xì)胞增殖作用的研究，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2008, (06), 742- 高澤俊，袁小青，沈捷，馬向華，王水，MAPKs通路在Leptin促人乳腺癌細(xì)胞系增殖中的機(jī)制研究，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2008, (11), 1410-劉學(xué)敏，王水，夏添松，王玨，劉曉安 慢病毒轉(zhuǎn)染綠色熒光蛋白對(duì)乳腺癌細(xì)胞系腫瘤干細(xì)胞相關(guān)亞群的影響， 中國(guó)組織工程研究與臨床康復(fù), 2008, (38), 7507-王水，乳管鏡技術(shù)臨床應(yīng)用及其診療價(jià)值，中國(guó)實(shí)用外科雜志, 2009, (03), 261- 顧則娟，王水，張鎮(zhèn)靜，王榮，謝曉峰，朱琳，戴曉冬，葉桂華，林征，方小平， 殷蓉，舒心病房護(hù)理運(yùn)行模式的建立與應(yīng)用，中華護(hù)理雜志, 2009, (10), 929- 宋兵，沈歷宗，徐皓，黃華興，肇毅，史京萍，王水外科實(shí)習(xí)生出科量化考核結(jié)果的研究分析與思考，臨床和實(shí)驗(yàn)醫(yī)學(xué)雜志, 2010, (05), 353- 傅衛(wèi)，王水，杜青，肇毅，查小明，劉曉安，巢式 RT-PCR 檢測(cè)乳腺癌外周血循環(huán)腫瘤細(xì)胞的臨床價(jià)值，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2010, (06), 818- 蔣超，丁強(qiáng)，王水，楊海偉，張煒明，F(xiàn)ISH 檢測(cè)乳腺癌石蠟組織切片的酶消化時(shí)間的探究，現(xiàn)代生物醫(yī)學(xué)進(jìn)展, 2010, (15), 2907- 陳翔，王水，乳腺癌前哨淋巴結(jié)活檢研究現(xiàn)狀及進(jìn)展，中國(guó)普外基礎(chǔ)與臨床雜志, 2011, (01), 98- 黃華興，沈歷宗，肇毅，凌立君，史京萍，徐皓，吳蔚，王水，PBL與LBL相結(jié)合在基礎(chǔ)外科學(xué)實(shí)踐教學(xué)中的應(yīng)用，南京醫(yī)科大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版), 2011, (03), 227- 崔一堯，王水，臨床推廣乳腺癌前哨淋巴結(jié)活檢技術(shù)的影響因素分析，中國(guó)醫(yī)學(xué)倫理學(xué), 2011, (05), 611- 黃華興，沈歷宗，肇毅，凌立君，史京萍，徐皓，吳蔚，王水，外科學(xué)基礎(chǔ)考試模式的改革與探討，南京醫(yī)科大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版), 2011, (06), 488- 崔一堯，王水，前哨淋巴結(jié)活檢在乳腺癌治療中的意義，醫(yī)學(xué)與哲學(xué)(臨床決策論壇版), 2011, (08), 41- 史京萍，夏添松，丁強(qiáng)，劉曉安，査小明，王水，CpG 寡核苷酸促進(jìn) Toll 樣受體 9 的表達(dá)增強(qiáng)乳腺癌細(xì)胞侵襲南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2011, (08), 1161- 崇梅紅，王水，乳腺癌血行微小轉(zhuǎn)移研究進(jìn)展，中華臨床醫(yī)師雜志(電子版), 2011, (10), 2970- 崇梅紅，王水，乳腺癌淋巴結(jié)微小轉(zhuǎn)移研究進(jìn)展，中華臨床醫(yī)師雜志(電子版), 2011, (11), 3254- 許立生，王水，黃中晶，沈恩超，錢(qián)超，人生長(zhǎng)激素對(duì)乳腺癌細(xì)胞增殖和凋亡的影響，天津醫(yī)藥, 2011, (12), 1141- 馬晶晶，王水，鄭明潔，繆蘇宇，徐露，王玨，乳腺癌細(xì)胞株兩種原代培養(yǎng)方法的比較，江蘇醫(yī)藥, 2011, (16), 1865- 劉釗，王水，孕激素及雌激素對(duì)乳腺癌細(xì)胞 RANKL 及其受體的調(diào)節(jié)作用，江蘇醫(yī)藥, 2011, (16), 1874- 許立生，王水，黃中晶，沈恩超，錢(qián)超，CD44~+/CD24~(-/low)/ABCG2~-乳腺癌干細(xì)胞與臨床治療及預(yù)后的關(guān)系，實(shí)用醫(yī)學(xué)雜志, 2011, (21), 3877- 崇梅紅，王水，查小明，劉曉安，凌立君，肇毅，實(shí)時(shí)熒光定量PCR法檢測(cè)乳腺癌外周血循環(huán)腫瘤細(xì)胞的臨床價(jià)值，南京醫(yī)科大學(xué)學(xué)報(bào)(自然科學(xué)版), 2012, (02), 220- 趙奕華，李鑫，王水，王虹，公立醫(yī)院改革背景下醫(yī)用耗材管理的困難與對(duì)策，中國(guó)醫(yī)療設(shè)備, 2012, (11), 100-周茜，王水，錢(qián)寧，劉小豐，陸澄，骨橋蛋白在乳腺癌組織中的表達(dá)及其與臨床病理和 p53 的關(guān)系，江蘇醫(yī)藥, 2012, (20), 2387- 許立生，王水，黃中晶，趙志泓，沈恩超，錢(qián)超，ER、PR、VEGF、CA15-3、CA125 和 CEA 水平在乳腺癌預(yù)后判斷中的臨床意義，實(shí)用醫(yī)學(xué)雜志, 2012, (21), 3565- 張桂普，王水，鄭明潔，王玨，“人源性”乳腺微環(huán)境促進(jìn)人源性乳腺癌細(xì)胞發(fā)生上皮細(xì)胞間充質(zhì)轉(zhuǎn)化，江蘇醫(yī)藥, 2012, (22), 2652- 王水，劉釗，乳腺神經(jīng)內(nèi)分泌癌，中國(guó)實(shí)用外科雜志, 2013, (03), 238- 姚秀蕾，肇毅，姚志勇，王水，超聲引導(dǎo)粗針活檢在觸診陰性乳腺腫瘤診斷中的臨床意義，中國(guó)醫(yī)藥導(dǎo)報(bào), 2013, (02), 41- 黃華興，張永杰，沈歷宗，肇毅，王水，整合外科與解剖教學(xué),架構(gòu)臨床與基礎(chǔ)橋梁，南京醫(yī)科大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版), 2013, (03), 273-周悅，黃華興，駱金華，陳亮，王水，胸腔鏡技術(shù)應(yīng)用以提高胸心外科教學(xué)效果的研究與實(shí)踐，南京醫(yī)科大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版), 2013, (05), 472- 楊小冬，黃華興，黃平，沈歷宗，王水，淺談外科學(xué)基礎(chǔ)實(shí)踐教學(xué)師資的選拔與培養(yǎng)，南京醫(yī)科大學(xué)學(xué)報(bào)(社會(huì)科學(xué)版), 2013, (06), 564- 朱倩男，夏添松，凌立君，王水，乳腺癌術(shù)后上肢淋巴水腫發(fā)生機(jī)制及預(yù)防進(jìn)展，中華乳腺病雜志(電子版), 2013, (06), 442- 王若曦，王水，乳腺癌 ER、PR 及 HER-2 在原發(fā)灶和轉(zhuǎn)移灶之間表達(dá)關(guān)系的研究進(jìn)展，江蘇醫(yī)藥, 2013, (08), 958-吳丹，劉曉安，查小明，王水，乳腺淋巴瘤 12 例臨床分析，江蘇醫(yī)藥, 2013, (14), 1660-吳蔚，沈歷宗，肇毅，凌立君，史京萍，黃華興，王水，積極心理學(xué)在外科學(xué)總論實(shí)驗(yàn)教學(xué)中的應(yīng)用，中國(guó)醫(yī)學(xué)創(chuàng)新, 2013, (34), 141-徐海萍，王娟，孫杰，王玨，王水，查小明，魯婷婷，孫茹萍，楊曉文，優(yōu)化乳腺癌健康宣教的探討，江蘇醫(yī)藥, 2014, (05), 604-606